- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The application scenarios of Pursennid laxatives in preoperative bowel cleansing and treatment of refractory constipation need to be strictly ...
As a laxative containing sennid, Pursennid Tablets mainly have gastrointestinal reactions as side effects, and long-term use may lead to depe...
PursennidTablets, as a commonly used laxative in Japan, contains sennid glycosides that are effective in treating chronic constipation and preo...
PursennidTablets is a commonly used laxative for clearing intestinal constipation in Japan. Its main ingredient is sennid, which exerts a laxat...
Coenzyme Q10 (Neuquinon) is generally safe as a metabolic stimulant, but attention should be paid to the risk of interaction when used in combi...
Coenzyme Q10 is an endogenous lipid soluble antioxidant that plays a crucial role in energy metabolism and cell protection as a key component o...
Belzutifan is the first approved HIF-2 α inhibitor for the treatment of VHL syndrome associated renal cell carcinoma, exerting anti-tumor effec...
Welireg, as the first approved HIF-2 α inhibitor for the treatment of VHL syndrome associated renal cell carcinoma, has shown significant tumor...
When Belzutifan is used to treat VHL related tumors, it is important to focus on managing common adverse reactions such as anemia, hypoxia, and...
Belzutifan is a novel HIF-2 α inhibitor that provides a new targeted therapy option for patients with inoperable VHL related tumors. This drug ...
